Respiratory Syncytial Virus in Older Adults: Understanding Risk, Diagnosis, and Evolving Prevention Strategies

Download All
Brush up on risk factors for RSV to better manage your adult patients and review the latest advances in RSV vaccine development in these interactive on-demand webcasts and expert-authored commentaries.
person default
Elliott Bosco, PharmD, PhD
person default
Angela Branche, MD
Spencer Durham Headshot
Spencer H. Durham, PharmD, BCPS, BCIDP
Barbara Resnick, PhD, CRNP


There is a growing recognition of the effects of RSV among older adults, particularly those in long-term care facilities. Here’s my take on how preventing transmission can save millions in healthcare costs.

person default Elliott Bosco, PharmD, PhD Released: August 11, 2021

Vaccines are at the forefront of the national consciousness, and manufacturers of the highly effective COVID-19 vaccines have entered the race to find an effective RSV vaccine.

Spencer Durham Headshot Spencer H. Durham, PharmD, BCPS, BCIDP Released: October 28, 2021

The potential availability of an effective RSV vaccine for older individuals is on the horizon, and with it comes numerous ways to address vaccine hesitancy in this patient population.

Barbara Resnick, PhD, CRNP Released: January 12, 2022

We are closer than ever to finding an effective RSV vaccine, but recent challenges may delay approval.

person default Angela Branche, MD Released: April 7, 2022
This activity is provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Educational grant provided by:
Janssen Therapeutics, Division of Janssen Products, LP

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings